TELA Bio Expects Full Year 2024 Revenue Of $74M-$76M, Representing 27%-30% Y/Y Growth; Est $75.196M
Portfolio Pulse from Benzinga Newsdesk
TELA Bio projects its full-year 2024 revenue to be between $74M and $76M, indicating a year-over-year growth of 27% to 30%. The estimated midpoint for this projection is $75.196M.
March 21, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TELA Bio expects a significant revenue growth for the full year 2024, projecting revenues to be between $74M and $76M, which represents a 27% to 30% increase from the previous year.
The projected revenue growth for TELA Bio is a positive indicator of the company's financial health and future prospects. This significant year-over-year growth expectation is likely to be viewed positively by investors, potentially leading to an increase in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100